{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:52:55Z","timestamp":1777398775888,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was supported by the Senior Medical Talents Program of Chongqing for Young and Middle-aged","award":["2022-15"],"award-info":[{"award-number":["2022-15"]}]},{"name":"the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","award":["kryc-gg-2117"],"award-info":[{"award-number":["kryc-gg-2117"]}]},{"name":"the program of Science and Technology Bureau of Yuzhong District, Chongqing","award":["20200145"],"award-info":[{"award-number":["20200145"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81701709"],"award-info":[{"award-number":["81701709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substantially challenging. Abnormal tumor vessels play a crucial role in TNBC progression and treatment. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis, while effective NO delivery can normalize the tumor vasculature. Accordingly, we have proposed here a tumor vascular microenvironment remodeling strategy based on NO-induced vessel normalization and extracellular matrix collagen degradation with multimodality imaging-guided nanoparticles against TNBC called DNMF\/PLGA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nanoparticles were synthesized using a chemotherapeutic agent doxorubicin (DOX), a NO donor L-arginine (L-Arg), ultrasmall spinel ferrites (MnFe<jats:sub>2<\/jats:sub>O<jats:sub>4<\/jats:sub>), and a poly (lactic-co-glycolic acid) (PLGA) shell. Nanoparticle distribution in the tumor was accurately monitored in real-time through highly enhanced magnetic resonance imaging and photoacoustic imaging. Near-infrared irradiation of tumor cells revealed that MnFe<jats:sub>2<\/jats:sub>O<jats:sub>4<\/jats:sub> catalyzes the production of a large amount of reactive oxygen species (ROS) from H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>, resulting in a cascade catalysis of L-Arg to trigger NO production in the presence of ROS. In addition, DOX activates niacinamide adenine dinucleotide phosphate oxidase to generate and supply H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>. The generated NO improves the vascular endothelial cell integrity and pericellular contractility to promote vessel normalization and induces the activation of endogenous matrix metalloproteinases (mainly MMP-1 and MMP-2) so as to promote extravascular collagen degradation, thereby providing an auxiliary mechanism for efficient nanoparticle delivery and DOX penetration. Moreover, the chemotherapeutic effect of DOX and the photothermal effect of MnFe<jats:sub>2<\/jats:sub>O<jats:sub>4<\/jats:sub> served as a chemo-hyperthermia synergistic therapy against TNBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The two therapeutic mechanisms, along with an auxiliary mechanism, were perfectly combined to enhance the therapeutic effects. Briefly, multimodality image-guided nanoparticles provide a reliable strategy for the potential application in the fight against TNBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-024-02366-y","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T17:02:30Z","timestamp":1710349350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Nitric oxide nano-reactor DNMF\/PLGA enables\u00a0tumor vascular microenvironment and chemo-hyperthermia synergetic therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Ruoyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chier","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenpei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"2366_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"2366_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"2366_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"2366_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.annonc.2021.06.002","volume":"32","author":"A Bardia","year":"2021","unstructured":"Bardia A, Tolaney SM, Punie K, Loirat D, Oliveira M, Kalinsky K, Zelnak A, Aftimos P, Dalenc F, Sardesai S, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021;32:1148\u201356.","journal-title":"Ann Oncol"},{"key":"2366_CR5","doi-asserted-by":"publisher","first-page":"2189118","DOI":"10.1080\/10717544.2023.2189118","volume":"30","author":"T Zhang","year":"2023","unstructured":"Zhang T, Li N, Wang R, Sun Y, He X, Lu X, Chu L, Sun K. Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity. Drug Deliv. 2023;30:2189118.","journal-title":"Drug Deliv"},{"key":"2366_CR6","unstructured":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 2018;19:27\u201339."},{"key":"2366_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1634\/theoncologist.2017-0672","volume":"23","author":"AN Shah","year":"2018","unstructured":"Shah AN, Gradishar WJ. Adjuvant anthracyclines in breast cancer: what is their role? Oncologist. 2018;23:1153\u201361.","journal-title":"Oncologist"},{"key":"2366_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238\u201350.","journal-title":"Semin Cancer Biol"},{"key":"2366_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer. 2022;8:95.","journal-title":"NPJ Breast Cancer"},{"key":"2366_CR10","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak KGK, Vempati R, Nagaraju GP, Dasari VR. S N, Rao DN, Malla RR: Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683.","journal-title":"Pharmacol Res"},{"key":"2366_CR11","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.1002\/anie.201800594","volume":"57","author":"W Fan","year":"2018","unstructured":"Fan W, Yung BC, Chen X. Stimuli-responsive no release for on-demand gas-sensitized synergistic cancer therapy. Angew Chem Int Ed Engl. 2018;57:8383\u201394.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2366_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","volume":"116","author":"G Eelen","year":"2015","unstructured":"Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116:1231\u201344.","journal-title":"Circ Res"},{"key":"2366_CR13","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s00018-019-03182-6","volume":"76","author":"VR Krishnaswamy","year":"2019","unstructured":"Krishnaswamy VR, Benbenishty A, Blinder P, Sagi I. Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights. Cell Mol Life Sci. 2019;76:3229\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"2366_CR14","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/01.CIR.0000014928.45119.73","volume":"105","author":"JP Cooke","year":"2002","unstructured":"Cooke JP, Losordo DW. Nitric oxide and angiogenesis. Circulation. 2002;105:2133\u20135.","journal-title":"Circulation"},{"key":"2366_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.phrs.2003.10.008","volume":"49","author":"SA Raghavan","year":"2004","unstructured":"Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 2004;49:397\u2013414.","journal-title":"Pharmacol Res"},{"issue":"829\u2013837","key":"2366_CR16","first-page":"837a","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(829\u2013837):837a\u2013837d.","journal-title":"Eur Heart J"},{"key":"2366_CR17","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"key":"2366_CR18","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.1021\/acs.est.8b05677","volume":"53","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Demokritou P, Ryan DK, Bello D. Comprehensive assessment of short-lived ROS and H(2)O(2) in laser printer emissions: assessing the relative contribution of metal oxides and organic constituents. Environ Sci Technol. 2019;53:7574\u201383.","journal-title":"Environ Sci Technol"},{"key":"2366_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2022.06.050","volume":"349","author":"SG Alamdari","year":"2022","unstructured":"Alamdari SG, Amini M, Jalilzadeh N, Baradaran B, Mohammadzadeh R, Mokhtarzadeh A, Oroojalian F. Recent advances in nanoparticle-based photothermal therapy for breast cancer. J Control Release. 2022;349:269\u2013303.","journal-title":"J Control Release"},{"key":"2366_CR20","doi-asserted-by":"publisher","first-page":"e1906799","DOI":"10.1002\/adma.201906799","volume":"32","author":"Y Li","year":"2020","unstructured":"Li Y, Zhao X, Liu X, Cheng K, Han X, Zhang Y, Min H, Liu G, Xu J, Shi J, et al. A bioinspired nanoprobe with multilevel responsive T(1) -weighted MR signal-amplification illuminates ultrasmall metastases. Adv Mater. 2020;32:e1906799.","journal-title":"Adv Mater"},{"key":"2366_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1021\/acs.accounts.2c00102","volume":"55","author":"EA Kras","year":"2022","unstructured":"Kras EA, Snyder EM, Sokolow GE, Morrow JR. Distinct coordination chemistry of Fe(III)-based MRI probes. Acc Chem Res. 2022;55:1435\u201344.","journal-title":"Acc Chem Res"},{"key":"2366_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tibtech.2011.01.006","volume":"29","author":"S Mallidi","year":"2011","unstructured":"Mallidi S, Luke GP, Emelianov S. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011;29:213\u201321.","journal-title":"Trends Biotechnol"},{"key":"2366_CR23","doi-asserted-by":"publisher","first-page":"e2201051","DOI":"10.1002\/adma.202201051","volume":"34","author":"J Wang","year":"2022","unstructured":"Wang J, Dong Y, Ma P, Wang Y, Zhang F, Cai B, Chen P, Liu BF. Intelligent micro-\/nanorobots for cancer theragnostic. Adv Mater. 2022;34:e2201051.","journal-title":"Adv Mater"},{"key":"2366_CR24","doi-asserted-by":"publisher","first-page":"0015","DOI":"10.34133\/bmef.0015","volume":"4","author":"D Jin","year":"2023","unstructured":"Jin D, Zhu Y, Liu M, Yu W, Yu J, Zheng X, Wang L, Wu Y, Wei K, Cheng J, Liu Y. A leaking-proof theranostic nanoplatform for tumor-targeted and dual-modality imaging-guided photodynamic therapy. BME Front. 2023;4:0015.","journal-title":"BME Front"},{"key":"2366_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jconrel.2023.09.039","volume":"363","author":"S Liu","year":"2023","unstructured":"Liu S, Wang Z, Wei Q, Duan X, Liu Y, Wu M, Ding J. Biomaterials-enhanced bioactive agents to efficiently block spinal metastases of cancers. J Control Release. 2023;363:721\u201332.","journal-title":"J Control Release"},{"key":"2366_CR26","doi-asserted-by":"publisher","first-page":"e2006892","DOI":"10.1002\/adma.202006892","volume":"33","author":"LH Fu","year":"2021","unstructured":"Fu LH, Wan Y, Qi C, He J, Li C, Yang C, Xu H, Lin J, Huang P. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33:e2006892.","journal-title":"Adv Mater"},{"key":"2366_CR27","doi-asserted-by":"publisher","first-page":"0020","DOI":"10.34133\/bmef.0020","volume":"2023","author":"J Yang","year":"2023","unstructured":"Yang J, Ding J. Nanoantidotes: a detoxification system more applicable to clinical practice. BME Front. 2023;2023:0020.","journal-title":"BME Front"},{"key":"2366_CR28","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1039\/D2CS00247G","volume":"51","author":"X Ma","year":"2022","unstructured":"Ma X, Li SJ, Liu Y, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Bioengineered nanogels for cancer immunotherapy. Chem Soc Rev. 2022;51:5136\u201374.","journal-title":"Chem Soc Rev"},{"key":"2366_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2021.10.004","volume":"17","author":"P Zheng","year":"2022","unstructured":"Zheng P, Ding J. Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy. Asian J Pharm Sci. 2022;17:1\u20133.","journal-title":"Asian J Pharm Sci"},{"issue":"19","key":"2366_CR30","doi-asserted-by":"publisher","first-page":"e2100850","DOI":"10.1002\/advs.202100850","volume":"8","author":"J Yao","year":"2021","unstructured":"Yao J, Yang Z, Huang L, Yang C, Wang J, Cao Y, Hao L, Zhang L, Zhang J, Li P, et al. Low-intensity focused ultrasound-responsive ferrite-encapsulated nanoparticles for atherosclerotic plaque neovascularization theranostics. Adv Sci. 2021;8(19):e2100850.","journal-title":"Adv Sci"},{"key":"2366_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s13046-019-1443-1","volume":"38","author":"V Thakur","year":"2019","unstructured":"Thakur V, Kutty RV. Recent advances in nanotheranostics for triple negative breast cancer treatment. J Exp Clin Cancer Res. 2019;38:430.","journal-title":"J Exp Clin Cancer Res"},{"key":"2366_CR32","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/acsabm.2c00338","volume":"5","author":"H Ma","year":"2022","unstructured":"Ma H, Guo L, Zhang H, Wang Y, Miao Y, Liu X, Peng M, Deng X, Peng Y, Fan H. The metal ion release of manganese ferrite nanoparticles: kinetics, effects on magnetic resonance relaxivities, and toxicity. ACS Appl Bio Mater. 2022;5:3067\u201374.","journal-title":"ACS Appl Bio Mater"},{"key":"2366_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41551-022-00975-2","volume":"7","author":"H Zhang","year":"2023","unstructured":"Zhang H, Guo Y, Jiao J, Qiu Y, Miao Y, He Y, Li Z, Xia C, Li L, Cai J, et al. A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging. Nat Biomed Eng. 2023;7:221\u201335.","journal-title":"Nat Biomed Eng"},{"key":"2366_CR34","first-page":"100","volume":"12","author":"X Zhou","year":"2020","unstructured":"Zhou X, Meng Z, She J, Zhang Y, Yi X, Zhou H, Zhong J, Dong Z, Han X, Chen M, et al. Near-infrared light-responsive nitric oxide delivery platform for enhanced radioimmunotherapy. Nanomicro Lett. 2020;12:100.","journal-title":"Nanomicro Lett"},{"key":"2366_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/acs.nanolett.8b04236","volume":"19","author":"X Dong","year":"2019","unstructured":"Dong X, Liu HJ, Feng HY, Yang SC, Liu XL, Lai X, Lu Q, Lovell JF, Chen HZ, Fang C. Enhanced drug delivery by nanoscale integration of a nitric oxide donor to induce tumor collagen depletion. Nano Lett. 2019;19:997\u20131008.","journal-title":"Nano Lett"},{"key":"2366_CR36","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1021\/acsnano.9b05976","volume":"14","author":"S Gao","year":"2020","unstructured":"Gao S, Zhang W, Wang R, Hopkins SP, Spagnoli JC, Racin M, Bai L, Li L, Jiang W, Yang X, et al. Nanoparticles encapsulating nitrosylated maytansine to enhance radiation therapy. ACS Nano. 2020;14:1468\u201381.","journal-title":"ACS Nano"},{"key":"2366_CR37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41467-019-08670-8","volume":"10","author":"M Wan","year":"2019","unstructured":"Wan M, Chen H, Wang Q, Niu Q, Xu P, Yu Y, Zhu T, Mao C, Shen J. Bio-inspired nitric-oxide-driven nanomotor. Nat Commun. 2019;10:966.","journal-title":"Nat Commun"},{"key":"2366_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1349-7006.2011.01929.x","volume":"102","author":"Y Sato","year":"2011","unstructured":"Sato Y. Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy. Cancer Sci. 2011;102:1253\u20136.","journal-title":"Cancer Sci"},{"key":"2366_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bcp.2008.11.004","volume":"77","author":"S Viappiani","year":"2009","unstructured":"Viappiani S, Nicolescu AC, Holt A, Sawicki G, Crawford BD, Le\u00f3n H, van Mulligen T, Schulz R. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol. 2009;77:826\u201334.","journal-title":"Biochem Pharmacol"},{"key":"2366_CR40","doi-asserted-by":"publisher","first-page":"742483","DOI":"10.3389\/fcell.2021.742483","volume":"9","author":"F Wang","year":"2021","unstructured":"Wang F, Yuan Q, Chen F, Pang J, Pan C, Xu F, Chen Y. Fundamental mechanisms of the cell death caused by nitrosative stress. Front Cell Dev Biol. 2021;9:742483.","journal-title":"Front Cell Dev Biol"},{"key":"2366_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107 A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31:177\u201383.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2366_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2019.04.042","volume":"228","author":"A Kisling","year":"2019","unstructured":"Kisling A, Lust RM, Katwa LC. What is the role of peptide fragments of collagen I and IV in health and disease? Life Sci. 2019;228:30\u20134.","journal-title":"Life Sci"},{"key":"2366_CR43","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1038\/s41467-022-32255-7","volume":"13","author":"M Papanicolaou","year":"2022","unstructured":"Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL, Wyllie K, Tran E, Mok E, Nadalini A, et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun. 2022;13:4587.","journal-title":"Nat Commun"},{"key":"2366_CR44","first-page":"37","volume":"2","author":"JS Wey","year":"2004","unstructured":"Wey JS, Stoeltzing O, Ellis LM. Vascular endothelial growth factor receptors: expression and function in solid tumors. Clin Adv Hematol Oncol. 2004;2:37\u201345.","journal-title":"Clin Adv Hematol Oncol"},{"key":"2366_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/nm1197-1177a","volume":"3","author":"A Dembinska-Kiec","year":"1997","unstructured":"Dembinska-Kiec A, Dulak J, Partyka L, Huk I, Mailnski T. VEGF-nitric oxide reciprocal regulation. Nat Med. 1997;3:1177.","journal-title":"Nat Med"},{"key":"2366_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eplepsyres.2012.02.015","volume":"101","author":"R Adabi Mohazab","year":"2012","unstructured":"Adabi Mohazab R, Javadi-Paydar M, Delfan B, Dehpour AR. Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice. Epilepsy Res. 2012;101:28\u201335.","journal-title":"Epilepsy Res"},{"key":"2366_CR47","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1089\/ars.2018.7695","volume":"31","author":"V Tseng","year":"2019","unstructured":"Tseng V, Sutliff RL, Hart CM. Redox biology of peroxisome proliferator-activated receptor-\u03b3 in pulmonary hypertension. Antioxid Redox Signal. 2019;31:874\u201397.","journal-title":"Antioxid Redox Signal"},{"key":"2366_CR48","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","volume":"476","author":"W Qin","year":"2021","unstructured":"Qin W, Cao L, Massey IY. Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476:4045\u201359.","journal-title":"Mol Cell Biochem"},{"key":"2366_CR49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11912-023-01372-x","volume":"25","author":"D Wekking","year":"2023","unstructured":"Wekking D, Porcu M, De Silva P, Saba L, Scartozzi M, Solinas C. Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis. Curr Oncol Rep. 2023;25:257\u201367.","journal-title":"Curr Oncol Rep"},{"key":"2366_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/smll.201502309","volume":"12","author":"Z Gao","year":"2016","unstructured":"Gao Z, Ma T, Zhao E, Docter D, Yang W, Stauber RH, Gao M. Small is smarter: Nano MRI contrast agents\u2014advantages and recent achievements. Small. 2016;12:556\u201376.","journal-title":"Small"},{"key":"2366_CR51","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011\u201327.","journal-title":"J Clin Oncol"},{"key":"2366_CR52","doi-asserted-by":"publisher","first-page":"300060520905985","DOI":"10.1177\/0300060520905985","volume":"48","author":"Y Hu","year":"2020","unstructured":"Hu Y, Xiang J, Su L, Tang X. The regulation of nitric oxide in tumor progression and therapy. J Int Med Res. 2020;48:300060520905985.","journal-title":"J Int Med Res"},{"key":"2366_CR53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/jclinpath-2018-205536","volume":"72","author":"MR Kraby","year":"2019","unstructured":"Kraby MR, Opdahl S, Russnes HG, Bofin AM. Microvessel density in breast cancer: the impact of field area on prognostic informativeness. J Clin Pathol. 2019;72:304\u201310.","journal-title":"J Clin Pathol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02366-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02366-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02366-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T21:21:16Z","timestamp":1710624076000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02366-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02366-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}